Literature DB >> 9843065

Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies.

K Iwasa1, K Komai, M Takamori.   

Abstract

The mechanism of muscle weakness in myasthenia gravis and its possible relation to antibodies that are directed against the ryanodine receptor (RyR) were studied by the use of the spontaneous thymoma rat (Buffalo/Mna strain). The present study focused on the motor dysfunction as complicated by impaired subcellular machineries and noted particularly in patients with thymus abnormalities. Rats began to develop skeletal muscle weakness soon after birth and worsened progressively. Rats aged 3 months showed a benign thymoma characterized by proliferative lymphocytes; epithelial cells were stained with anti-RyR peptide antibody. The rat serum contained anti-RyR antibodies, but no anti-acetylcholine receptor antibodies. The electrophysiological study in muscle showed a reduction of contractile force without abnormality in synaptic transmission and membrane properties, suggesting a defect in excitation-contraction coupling. Hypothetically, thymic epithelial cells and skeletal muscles share a common RyR antigen, so that anti-RyR antibodies that target the thymic tissue may react with a homologous target in the muscle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843065     DOI: 10.1002/(sici)1097-4598(199812)21:12<1655::aid-mus5>3.0.co;2-f

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

Review 1.  Genetic models: clues for understanding the pathogenesis of idiopathic nephrotic syndrome.

Authors:  Corinne Antignac
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Authors:  Y Nemoto; S Kuwabara; S Misawa; N Kawaguchi; T Hattori; M Takamori; A Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

3.  Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats.

Authors:  Ludmilla Le Berre; Yann Godfrin; Eberhard Günther; Françoise Buzelin; Sabine Perretto; Helga Smit; Dontscho Kerjaschki; Claire Usal; Cristina Cuturi; Jean-Paul Soulillou; Jacques Dantal
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Is there B cell involvement in a rat model of spontaneous idiopathic nephrotic syndrome treated with LF15-0195?

Authors:  Ludmilla Le Berre; Gaëlle Tilly; Jacques Dantal
Journal:  J Nephrol       Date:  2014-03-25       Impact factor: 3.902

5.  Thymoma in myasthenia gravis: from diagnosis to treatment.

Authors:  Fredrik Romi
Journal:  Autoimmune Dis       Date:  2011-08-10

6.  Three types of striational antibodies in myasthenia gravis.

Authors:  Shigeaki Suzuki; Kimiaki Utsugisawa; Yuriko Nagane; Norihiro Suzuki
Journal:  Autoimmune Dis       Date:  2011-07-17

Review 7.  Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

Authors:  Roberta Bertelli; Alice Bonanni; Gianluca Caridi; Alberto Canepa; G M Ghiggeri
Journal:  Front Med (Lausanne)       Date:  2018-06-11

8.  Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.

Authors:  Masaharu Takamori
Journal:  Front Mol Neurosci       Date:  2020-05-28       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.